1. Home
  2. PMAX vs SCNI Comparison

PMAX vs SCNI Comparison

Compare PMAX & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Max Limited

PMAX

Powell Max Limited

BUY

Current Price

$3.31

Market Cap

4.5M

Sector

N/A

ML Signal

BUY

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$1.20

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMAX
SCNI
Founded
2019
2003
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.6M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
PMAX
SCNI
Price
$3.31
$1.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7M
42.2K
Earning Date
09-23-2025
11-24-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$4,799,100.00
$1,147,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.55
Revenue Growth
N/A
303.87
52 Week Low
$1.56
$0.86
52 Week High
$25.44
$6.18

Technical Indicators

Market Signals
Indicator
PMAX
SCNI
Relative Strength Index (RSI) 74.38 57.11
Support Level $1.56 $0.99
Resistance Level $3.04 $1.15
Average True Range (ATR) 0.29 0.09
MACD 0.16 0.04
Stochastic Oscillator 97.77 100.00

Price Performance

Historical Comparison
PMAX
SCNI

About PMAX Powell Max Limited

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: